Medical Advisory Board
ENGLISH DEUTSCH
WILEX has established several Medical Advisory Boards, which are made up of international experts in the fields of biology and medicine, in particular oncologists, urologists and radiologists. The Medical Advisory Boards advise WILEX on clinical trials and scientific matters.
- RENCAREX®
Arie Belldegrun, MD, FACS (Chairman of the Advisory Board)
Roy and Carol Doumani Chair in Urologic Oncology; Professor of Urology; and Chief, Division of Urologic Oncology; Department of Urology at the David Geffen School of Medicine at UCLA, Los Angeles, CA.
Michael B. Atkins, MD
Deputy Director Division of Hematology/Oncology, Beth Israel Deaconess Medical Center; Leader of the Renal Cancer Program, Dana Farber-Harvard Cancer Center; Professor of Medicine, Harvard Medical School, Boston, MA.
Michael L. Blute, MD
Chief of Urology, Department of Urology, Massachusetts General Hospital, Boston, MA
Nicholas Vogelzang, MD
Chair and Medical Director Developmental Therapeutics and Co-Chair GU Committee, US Oncology Research, Comprehensive Cancer Centers of NV, Las Vegas, USA
- REDECTANE®
Chaitanya Divgi, M.D.
Professor of Radiology; Vice-Chair, Research Department of Radiology at the Columbia University and Director at the Kreitchman PET Center at the Columbia University Medical Center, New York, NY, USA
Constantine Gatsonis, Ph.D.
Henry Ledyard Goddard University Professor of Biostatistics; Chair of the Department of Biostatistics and Director of the Center for Statistical Sciences, Public Health Program at the Brown University, Providence, RI, USA
Paul Russo, M.D., FACS
Attending surgeon and Professor of Urology at the Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, New York, NY, USA
Robert G. Uzzo, M.D., FACS
G. Willing “Wing” Pepper Chair in Cancer Research, Professor of Surgical Oncology and Chairman of the Department of Surgery at the Fox Chase Cancer Center at the Temple University School of Medicine, Philadelphia, PA, USA
- Small Molecules Kinase Inhibitors
Roger B. Cohen, M.D.
Professor of Medical Oncology, Director Phase I Clinical Trials Program, Co-Leader Developmental Therapeutics Program, Fox Chase Cancer Center Philadelphia, Pennsylvania, USA
Prof. Herbie Newell
Professor of Cancer Therapeutics at the Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Medical School, Newcastle upon Tyne, UK
Prof. Paul Workman PhD DSc FMedSci
Harrap Professor of Pharmacology & Therapeutics, Director of the Cancer Research UK Centre for Cancer Therapeutics , Cancer Research UK Life Fellow, Leader of the Signal Transduction and Molecular Pharmacology Team and Co-Team Leader of the Clinical Pharmacology and Trials Team, The Institute for Cancer Research (ICR), Sutton, UK
Prof. Ruth Plummer
Director, Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK
